BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 2067120)

  • 1. Activity of a short course of interferon alpha for metastatic renal cell carcinoma--a phase-2 study.
    Abratt RP; Pontin AR; Ball HS
    Cancer Immunol Immunother; 1993 Jul; 37(2):140-1. PubMed ID: 8319243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets.
    Nguyen PL; Cho J
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of advanced renal cell carcinoma with interferon alpha and OK-432 (streptococcal preparation)].
    Shinoda M; Naide Y
    Hinyokika Kiyo; 1992 Nov; 38(11):1299-304. PubMed ID: 1485585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Taylor W; Laszlo J
    Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kinouchi T; Saiki S; Maeda O; Kuroda M; Usami M; Kotake T
    J Urol; 1997 May; 157(5):1604-7. PubMed ID: 9112486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
    Ishito N; Wada F; Aramaki K; Asano S; Johsen T
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
    Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
    Ibayashi K; Ando M; Gotoh E
    Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon alpha and gamma in the treatment of renal cell carcinoma].
    Kawai K; Sato K; Nishijima Y; Sasaki A; Yamashita J; Ishikawa H; Koiso K
    Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):231-6. PubMed ID: 2112656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant beta-interferon in the treatment of patients with metastatic renal cell carcinoma.
    Mani S; Todd M; Poo WJ
    Am J Clin Oncol; 1996 Apr; 19(2):187-9. PubMed ID: 8610647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma.
    Rizzo M; Bartoletti R; Selli C; Sicignano A; Criscuolo D
    Eur Urol; 1989; 16(4):271-7. PubMed ID: 2670581
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.